Your browser doesn't support javascript.
loading
Real-World Efficacy Outcomes of FLT3-ITDmut Acute Myeloid Leukemia Patients Treated with Midostaurin in Combination with Intensive Induction.
Gueta, Itai; Marcu-Malina, Victoria; Avigdor, Abraham; Shimoni, Avichai; Loebstein, Ronen; Canaani, Jonathan.
Affiliation
  • Gueta I; Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
  • Marcu-Malina V; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
  • Avigdor A; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
  • Shimoni A; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
  • Loebstein R; Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
  • Canaani J; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel. Electronic address: Jonathan.canaani@sheba.health.gov.il.
Clin Lymphoma Myeloma Leuk ; 23(2): 154-157, 2023 02.
Article in En | MEDLINE | ID: mdl-36564312
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Limits: Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Israel
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Limits: Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Israel